Neuberger Berman Group LLC Sells 1,121 Shares of Danaher Co. (NYSE:DHR)

Neuberger Berman Group LLC trimmed its stake in shares of Danaher Co. (NYSE:DHR) by 0.1% in the second quarter, HoldingsChannel.com reports. The fund owned 1,837,346 shares of the conglomerate’s stock after selling 1,121 shares during the quarter. Neuberger Berman Group LLC’s holdings in Danaher were worth $324,619,000 at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in the company. Jag Capital Management LLC lifted its position in shares of Danaher by 1.2% during the 2nd quarter. Jag Capital Management LLC now owns 4,394 shares of the conglomerate’s stock valued at $777,000 after acquiring an additional 51 shares during the period. Covenant Asset Management LLC lifted its position in shares of Danaher by 1.8% during the 2nd quarter. Covenant Asset Management LLC now owns 2,992 shares of the conglomerate’s stock worth $529,000 after buying an additional 52 shares during the last quarter. Baystate Wealth Management LLC lifted its position in shares of Danaher by 2.6% during the 2nd quarter. Baystate Wealth Management LLC now owns 2,024 shares of the conglomerate’s stock worth $358,000 after buying an additional 52 shares during the last quarter. FARMERS & MERCHANTS TRUST Co OF LONG BEACH lifted its position in shares of Danaher by 0.6% during the 2nd quarter. FARMERS & MERCHANTS TRUST Co OF LONG BEACH now owns 8,929 shares of the conglomerate’s stock worth $1,579,000 after buying an additional 54 shares during the last quarter. Finally, First Horizon Advisors Inc. lifted its position in shares of Danaher by 1.5% during the 2nd quarter. First Horizon Advisors Inc. now owns 3,539 shares of the conglomerate’s stock worth $626,000 after buying an additional 54 shares during the last quarter. Hedge funds and other institutional investors own 78.01% of the company’s stock.

In other news, Director Linda P. Hefner sold 2,754 shares of the stock in a transaction dated Monday, July 27th. The stock was sold at an average price of $197.00, for a total value of $542,538.00. Following the completion of the sale, the director now owns 32,749 shares of the company’s stock, valued at $6,451,553. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, SVP Angela S. Lalor sold 77,909 shares of the stock in a transaction dated Monday, August 31st. The shares were sold at an average price of $205.50, for a total value of $16,010,299.50. Following the completion of the sale, the senior vice president now directly owns 52,445 shares of the company’s stock, valued at approximately $10,777,447.50. The disclosure for this sale can be found here. In the last three months, insiders sold 530,474 shares of company stock valued at $104,501,669. Insiders own 11.70% of the company’s stock.

Shares of DHR stock traded up $0.75 on Tuesday, hitting $208.68. The company had a trading volume of 56,495 shares, compared to its average volume of 2,985,939. The firm has a market cap of $147.51 billion, a P/E ratio of 44.70, a P/E/G ratio of 3.22 and a beta of 0.91. The stock’s 50-day moving average is $203.85 and its two-hundred day moving average is $171.34. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.74 and a current ratio of 2.20. Danaher Co. has a twelve month low of $119.60 and a twelve month high of $210.57.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Thursday, July 23rd. The conglomerate reported $1.44 earnings per share for the quarter, beating the consensus estimate of $1.09 by $0.35. The company had revenue of $5.30 billion during the quarter, compared to analysts’ expectations of $5.01 billion. Danaher had a return on equity of 11.88% and a net margin of 17.73%. The business’s quarterly revenue was up 2.7% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.09 earnings per share. Equities research analysts predict that Danaher Co. will post 5.47 EPS for the current year.

DHR has been the subject of several recent analyst reports. Stifel Nicolaus upped their price objective on Danaher from $170.00 to $210.00 and gave the stock a “hold” rating in a research report on Friday, July 24th. Bank of America upped their price objective on Danaher from $181.00 to $215.00 and gave the stock a “buy” rating in a research report on Monday, July 20th. Royal Bank of Canada upped their price objective on Danaher from $205.00 to $218.00 and gave the stock an “outperform” rating in a research report on Friday, July 24th. Robert W. Baird upped their target price on Danaher from $163.00 to $205.00 and gave the stock an “outperform” rating in a report on Friday, July 24th. Finally, Wolfe Research raised Danaher from a “peer perform” rating to an “outperform” rating and set a $195.00 target price for the company in a report on Tuesday, June 16th. Two analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and an average target price of $197.73.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments; Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.

Featured Article: Hedge Funds – How They Work For Investors

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.